These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 28288505
1. The use of immunosuppression in autoimmune hepatitis: A current literature review. Cropley A, Weltman M. Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505 [Abstract] [Full Text] [Related]
3. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. Richardson PD, James PD, Ryder SD. J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991 [Abstract] [Full Text] [Related]
4. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Baven-Pronk AM, Coenraad MJ, van Buuren HR, de Man RA, van Erpecum KJ, Lamers MM, Drenth JP, van den Berg AP, Beuers UH, den Ouden J, Koek GH, van Nieuwkerk CM, Bouma G, Brouwer JT, van Hoek B. Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459 [Abstract] [Full Text] [Related]
12. Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial. Snijders RJALM, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Pronk MAMCB, Beuers UHW, van der Meer AJ, van Gerven NMF, Sijtsma MGM, Verwer BJ, Gisbertz IAM, Bartelink M, van den Brand FF, Sebib Korkmaz K, van den Berg AP, Guichelaar MMJ, Soufidi K, Levens AD, van Hoek B, Drenth JPH, Dutch Autoimmune Hepatitis Working Group. Trials; 2022 Dec 13; 23(1):1012. PubMed ID: 36514163 [Abstract] [Full Text] [Related]
14. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis. Yu ZJ, Zhang LL, Huang TT, Zhu JS, He ZB. Eur J Gastroenterol Hepatol; 2019 Jul 13; 31(7):873-877. PubMed ID: 31150366 [Abstract] [Full Text] [Related]
15. Clinical management of autoimmune hepatitis. Pape S, Schramm C, Gevers TJ. United European Gastroenterol J; 2019 Nov 13; 7(9):1156-1163. PubMed ID: 31700628 [Abstract] [Full Text] [Related]
16. Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil. Liberal R, Gaspar R, Lopes S, Macedo G. Clin Res Hepatol Gastroenterol; 2021 Mar 13; 45(2):101487. PubMed ID: 32651078 [Abstract] [Full Text] [Related]
18. First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients. Dalekos GN, Arvaniti P, Gatselis NK, Samakidou A, Gabeta S, Rigopoulou E, Koukoulis GK, Zachou K. Front Immunol; 2021 Mar 13; 12():798602. PubMed ID: 35087524 [Abstract] [Full Text] [Related]
19. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Devlin SM, Swain MG, Urbanski SJ, Burak KW. Can J Gastroenterol; 2004 May 13; 18(5):321-6. PubMed ID: 15152283 [Abstract] [Full Text] [Related]
20. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience. Wolf DC, Bojito L, Facciuto M, Lebovics E. Dig Dis Sci; 2009 Nov 13; 54(11):2519-22. PubMed ID: 19082888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]